<DOC>
	<DOCNO>NCT01946945</DOCNO>
	<brief_summary>We propose perform clinical randomize trial evaluate effect blastocyst biopsy whole chromosome analysis Next Generation Sequencing ( NGS ) comparison standard Assisted Reproductive Technologies ( ART ) methods implantation rate , miscarriage rate , pregnancy rate . This three study one : ) comparison treatment ( NGS ) treatment , b ) non-selection study base control group replace without know ploidy embryo , know later , c ) retrospective study use Mitochondrial DNA selection tool .</brief_summary>
	<brief_title>Comparison Standard ART Practice vs. Trophectoderm Biopsy Whole Chromosome Analysis</brief_title>
	<detailed_description>Patients follow inclusion criterion randomize two group : 1 . Control group : All blastocyst embryos biopsied day 5/6 , biopsy freeze analyzed replacement . Blastocyst embryos vitrified future frozen embryo transfer ( FET ) cycle . Patients single hatch blastocyst ( * ) thaw transfer uterus FET cycle base standard embryo quality assessment without NGS . After transfer , biopsied sample analyze ( replace embryo also , order non-selection study ) . If patient control group pregnancy term FET cycle , euploid frozen blastocyst thaw transfer next FET transfer . 2 . Test group : All blastocyst embryos biopsied day 5/6 , biopsy analyze use NGS . ( * ) Biopsied blastocyst embryo vitrify future frozen embryo transfer ( FET ) cycle . Patients single hatch euploid blastocyst ( * ) thaw transfer uterus FET cycle ( * ) Hatching blastocyst describe Gardner Schoolcraft ( 1999 ) The Primary efficacy endpoint compare study group control ongoing implantation rate ( # fetus reach 2nd trimester / # embryos replace ) . All biopsied embryos test control group mitochondrial DNA analyze , information use purpose choose embryos replacement . Retrospectively blindly ( see blind result section ) , information use end study determine embryo high chance implanting . If point participate patient remain embryos frozen , able use information purpose embryo selection .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>All patient medically clear fresh frozen embryo transfer . Age 42 year microsurgical epididymal sperm aspiration ( MESA ) Testicular sperm extraction ( TESE ) patient At least one partner carrier chromosomal genetic disease Abnormal ovarian reserve , define follicle stimulate hormone ( FSH ) &gt; 10 IU/L day 24 cycle antimullerian hormone ( AMH ) &lt; 1ng /ml ( If one two parameter alter patient acceptable ) . This base Mandy Katz abstract American Society Reproductive Medicine ( ASRM ) 2011 show patient 35 % chance euploid embryo They exclude make study size small , otherwise , euploid embryo find patient , implant well patient normal ovarian reserve . Not center AMH test recommend first run FSH test AMH FSH abnormal . Egg donor cycle ( sperm donor acceptable ) Gender selection cycle Thaw cycle</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>infertility</keyword>
	<keyword>recurrent pregnancy loss</keyword>
	<keyword>miscarriage</keyword>
	<keyword>Next Generation Sequencing</keyword>
</DOC>